ID: ALA4166519
Chembl Id: CHEMBL4166519
PubChem CID: 145953573
Max Phase: Preclinical
Molecular Formula: C21H15ClFN3O3
Molecular Weight: 411.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCc1nc2c(-c3ccc(Cl)cc3)nc3ccc(F)cc3c2c(=O)n1CC(=O)O
Standard InChI: InChI=1S/C21H15ClFN3O3/c1-2-16-25-20-18(21(29)26(16)10-17(27)28)14-9-13(23)7-8-15(14)24-19(20)11-3-5-12(22)6-4-11/h3-9H,2,10H2,1H3,(H,27,28)
Standard InChI Key: ZQUIEGKZSGIWOL-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 411.82 | Molecular Weight (Monoisotopic): 411.0786 | AlogP: 4.05 | #Rotatable Bonds: 4 |
| Polar Surface Area: 85.08 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 3.66 | CX Basic pKa: 2.70 | CX LogP: 3.84 | CX LogD: 0.78 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.51 | Np Likeness Score: -1.42 |
| 1. Crespo I, Giménez-Dejoz J, Porté S, Cousido-Siah A, Mitschler A, Podjarny A, Pratsinis H, Kletsas D, Parés X, Ruiz FX, Metwally K, Farrés J.. (2018) Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase., 152 [PMID:29705708] [10.1016/j.ejmech.2018.04.015] |
Source(1):
